Project Grant 1841732

This $256,000 National Science Foundation Project Grant under the Engineering (47.041) program will support the development of a permanent ceramic antimicrobial coating technology by Nanoionix, LLC. The goal is to synthesize and deposit a pure ceramic coating on relevant substrates that exceeds EPA requirements for generating reactive oxygen species to inactivate viruses and bacteria. Nanoionix will conduct spectroscopic assessments to rapidly evaluate the types and numbers of reactive oxygen...

This $255,966 National Science Foundation Technology, Innovation, and Partnerships award to Nano-Product Engineering, LLC will support the development of an antiviral/antimicrobial micropowder for application to personal protective equipment and respiratory equipment surfaces. The award period is from September 15, 2022 through May 31, 2023. The project aims to improve the protective properties of commonly used PPE and respiratory equipment, which typically only provides passive protection and...

Carrisan Technologies Inc. received a $255,990 National Science Foundation Project Grant under the NSF Directorate for Engineering SBIR PHASE I program to develop persistent antimicrobial compositions to prevent cross-contamination via hands and gloves from May 2021 through April 2022. The NSF SBIR PHASE I program aims to support innovative research and development from small businesses and translate promising ideas into products and services with commercial potential or public benefit. Under...

The National Science Foundation Division of Industrial Innovation awarded a $256,000 Project Grant to Avior Inc., doing business as Avior Bio, to develop a safe and effective copper nanoparticle suspension formulation for face mask applications against SARS-CoV-2 and other viruses. The grant period runs from July 1, 2021 through December 31, 2021 under the Engineering (47.041) federal grant program. Through this funding, Avior Bio will work to produce a nanoparticle formulation that can be...

The National Science Foundation Division of Industrial Innovation awarded Quick-Med Technologies, Inc. a $255,999 Project Grant under the Engineering federal grant program (CFDA 47.041) to develop Regenerable Antimicrobial Paints Based on Hydrogen Peroxide. This award, issued on April 1, 2021 for completion by September 30, 2021, will support Quick-Med Technologies' efforts to improve the quality of life and economic strength of the nation by fostering innovation in engineering research....

Acatechol, Inc. was awarded a $274,982 National Science Foundation (NSF) Small Business Innovation Research (SBIR) Phase I grant to develop an innovative anti-infective coating for Foley catheters. The project aims to create a hybrid coating that combines biofilm-repellent and antimicrobial properties to provide prolonged resistance against pathogen colonization and catheter-associated urinary tract infections (CAUTIs). This work is being conducted under the NSF Technology, Innovation, and...

This National Science Foundation (NSF) Small Business Innovation Research (SBIR) Phase I award to Bactria Pharmaceuticals LLC is providing $274,937 to develop therapeutic drugs that restore antibiotic sensitivity in bacteria that cause severe healthcare-associated infections. The goal is to combat antimicrobial resistance in gram-negative pathogens through the use of small molecule efflux pump inhibitors (EPIs). The project involves three key activities: cryo-electron microscopy to understand...

This SBIR Phase I Project Grant award from the National Science Foundation (CFDA 47.084 - NSF Technology, Innovation, and Partnerships) provides $305,000 to Glow Therapeutics Inc., a small minority-owned business, to advance the development of a novel light-activatable nanoplatform for the targeted co-delivery of photodynamic therapy (PDT) and chemotherapy to treat peritoneal metastasis. The nanoplatform is designed to selectively target and eliminate cancer cells that could not be removed by...

The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $299,995 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) to Xiretsa Inc., a minority-owned small business located in Santa Barbara, CA. The grant will fund the development of a novel class of antimicrobial compounds called Anti-Infective Conjugated Electrolytes (ACEs) that target the bacterial cell membrane to address the growing threat of antimicrobial resistance. The project...

This SBIR Phase I project, awarded by the National Science Foundation (NSF) under the NSF Technology, Innovation, and Partnerships (TIP) program (CFDA 47.084), aims to develop novel, sustainable textile fibers and fabrics derived from seaweed biopolymers and nanomaterials. The project seeks to create a plastic-free, multifunctional textile material with enhanced properties such as fire resistance, UV protection, and heat shielding, which can serve as an alternative to fossil fuel-based textiles....